MELISSA SELEYO: Open Payments
NPI 1023555299 · CORAOPOLIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$425 in 24 payments from 10 companies in 2025. Trend: 2023 $1,621 · 2024 $802 · 2025 $425
Food & beverage: $425
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 8 | $130 |
| ABBVIE INC. | 4 | $91 |
| Novo Nordisk Inc | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| Amgen Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: MOUNJARO, JARDIANCE, Ozempic, QULIPTA, AIRSUPRA, XIFAXAN, VRAYLAR, EVENITY.
Industry payments across PA — which companies pay providers there.
